Triple therapy in COPD: Oportunities and challenges Source: Short Video Statement 2020 Year: 2020
The right treatment for the right patient with COPD: lessons from the IMPACT trial Source: Eur Respir J, 55 (5) 2000881; 10.1183/13993003.00881-2020 Year: 2020
Triple therapy (ICS/LABA/LAMA) in COPD: thinking out of the box Source: ERJ Open Res, 5 (1) 00185-2018; 10.1183/23120541.00185-2018 Year: 2019
Talk from Athens – The optimal pharmacological therapy for the right COPD patient Source: ERS Satellites 2019 Year: 2019
LATE-BREAKING ABSTRACT: Single inhaler triple therapy (ICS/LAMA/LABA) in patients with advanced COPD: Results of the FULFIL trial Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities Year: 2016
Single-inhaler triple therapy in symptomatic COPD patients: FULFIL subgroup analyses Source: ERJ Open Res, 4 (2) 00119-2017; 10.1183/23120541.00119-2017 Year: 2018
Are we selecting the right inhaler for the right COPD patient? Source: Virtual Congress 2021 – Part I: restarting COPD care in the post-COVID era Year: 2021
Single inhaler triple therapy in advanced COPD patients: prior medication and disease severity FULFIL subanalyses Source: International Congress 2017 – COPD management Year: 2017
Triple therapy de-escalation to dual bronchodilation in COPD patients: Baseline data from the DACCORD cohort Source: Virtual Congress 2020 – Clinical studies of COPD: combination inhalers and much more Year: 2020
Evolving use of long-term NIV in COPD: Are we getting it right Source: Annual Congress 2013 –Long-term NIV: COPD, sleep, obesity and outcomes Year: 2013
Symptomatic burden of COPD for patients receiving dual or triple therapy Source: International Congress 2017 – Management of COPD Year: 2017
Long-term safety of bilateral targeted lung denervation in patients with COPD in a single procedure Source: International Congress 2015 – Bronchoscopic treatment of COPD and asthma: valves, coils, thermoplastics and something more Year: 2015
Single inhaler triple therapy in patients with COPD: patient-reported dyspnoea and health status from the IMPACT Trial Source: International Congress 2018 – Integrating pharmacological and non-pharmacological management in COPD: are we there yet? Year: 2018
Improving symptomology in COPD: which therapy would you choose, a brochodilator or pulmonary rehabilitation? Source: International Congress 2019 – Hot topics in pulmonary rehabilitation Year: 2019
Corticosteroid and long acting beta agonist combination inhalers in COPD: the right device for the right patient? Source: Eur Respir J 2005; 26: Suppl. 49, 293s Year: 2005
What is the scientific and clinical rationale? Triple therapy in COPD patients Source: Virtual Congress 2021 – Linking scientific mechanisms to recent clinical therapeutic advances in airway disease: why, who, when and what? Year: 2021
Real-world prescribing patterns among newly diagnosed COPD patients receiving ICS: An analysis of UK patient dataset Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments Year: 2014